Charting out a ‘Google Maps’ for the brain
HBHL-funded researchers have made groundbreaking progress towards creating an all-encompassing digital map of the brain. This effort comes out of the Helmholtz International BigBrain Analytics & Learning Laboratory (HIBALL) initiative combining neuroscience and artificial intelligence to build highly detailed 3D models of the brain at the cellular level.
Dr. Serge Gauthier featured on CTV News
Experts call for better dementia treatment in new report, saying most patients receive no care after diagnosis
Gauthier, a professor of neurology and psychiatry at McGill University and director of the Alzheimer Disease and Related Disorders Research Unit in the McGill Center for Studies in Aging, described dementia as “a combination of decline in function in the cognitive abilities, usually memory.
Dr. Tuong-Vi Nguyen featured on CBC Manitoba
How the U.K. model of postpartum depression care could guide Canada's treatment plan
Tuong-Vi Nguyen, an assistant professor in both the psychiatry and gynecology and obstetrics departments at McGill University, says the whole family suffers when the birthing parent experiences postpartum depression.
CBC Manitoba
Quebec study on long COVID seeking participants
Purpose is to understand post-COVID symptom evolution and impact on patients’ livesAs of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.
Dr. Cécile Rousseau featured in La Presse
Les orphelins de la COVID-19
L’autre élément important est la stigmatisation. « Avec le sida et l’Ebola, les orphelins sont souvent stigmatisés parce que ce sont des maladies qui font peur », explique Cécile Rousseau, psychiatre de l’Université McGill. « Je participe à un projet de recherche canadien sur les orphelins de l’Ebola et de la COVID-19 au Congo. »
Dr. Joel Paris featured in The Province
Doctors have stopped believing that 'chemical imbalance' causes depression. They didn't tell us
Psychiatry has known for some time that the “serotonin theory” of depression, the notion that too little of the brain chemical can be a cause of depression, a decades-old hypothesis and deeply entrenched trope in society that helped promote a class of antidepressants taken by millions of Canadians, is wrong, says Montreal psychiatrist Dr. Joel Paris.
New HBHL Research Theme 1 Leader: Blake Richards
We're happy to announce Blake Richards as the new Leader of Healthy Brains, Healthy Lives (HBHL) Research Theme 1: Neuroinformatics and Computational Modelling.
HBHL's Theme 1 Leader plays an essential role in HBHL’s governance and decision-making structure. They also provide critical guidance to HBHL's strategic research priorities, building and endorsing activities and funding initiatives aimed at reaching HBHL’s goals.
Dr. Gabriella Gobbi quoted in Le Droit
Le bras de fer du pot, 18 ou 21 ans?
«Ce qui dit qu’une année de loi a diminué la consommation chez les jeunes de 7 %. Du point de vue statistique épidémiologique, c’est énorme!» commente la Dre Gabriella Gobbi, psychiatre et professeure à l’Université McGill. Dre Gobbi avait témoigné devant la commission parlementaire qui étudiait le projet de loi no 2, en 2019.
Dr. Patricia Pelufo Silveira named as a Member of the Royal Society of Canada's College of New Scholars, Artist and Scientist
Dr. Patricia Pelufo Silveira was among the 54 newly elected Members of the Royal Society of Canada for 2022. The College of New Scholars, Artists and Scientists is Canada’s first national system of multidisciplinary recognition for the emerging generation of Canadian intellectual leadership. Congratulations Dr. Silveira!
Dr. Gabriella Gobbi awarded the CINP Sumitomo/Sunovion award
Dr. Gabriella Gobbi received the International College of Neuropsychopharmacology (CINP) Sumitomo/Sunovion Brain Health Basic Research award for her outstanding contribution in neuropsychopharmacology. The Neuroscience Research Awards are given to scientists in recognition of an outstanding contribution to psychopharmacology. Congratulations to Dr. Gobbi on this well-deserved achievement!
Muscle discovery, aging and memory, plus other stories
Muscle discovery may lead to better drugsThe smallest constituents of muscles, myosin and actin, may be targeted to contribute to more effective treatment methods against heart and muscle diseases, say a group of international researchers at McGill University and Linnaeus University.
Dr. Serge Gauthier interviewed on Radio-Canada
Hausse de cas de démence d'ici 2030 : Dr Serge Gauthier, neurologue
Two Neuro faculty inducted into The Royal Society of Canada
Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life
Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.
Dr. Veronique Bohbot quoted in Toronto Star
Hitting the road? Turn off the GPS, it’s bad for your brain
“We did spatial memory tests and found that degradation was correlated to GPS frequency,” said Véronique Bohbot, a scientist at the Douglas Research Centre and a professor of psychiatry at McGill University. “There was a difference between people who use GPS every day for every trip and the people who didn’t use GPS at all or just occasionally, say, once a month.”
Changing how we value research
The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research AssessmentThe Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.